Novavax, Inc. (NVAX) Reports In-Line Q1 EPS, Misses Revenue Expectations
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 -1.42%
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $834 thousand versus the consensus estimate of $2.29 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
